FindTrial
Sign In

Right Ventricle function in reversible pulmonary hypertension

Assessment of Right Ventricular Function in Patients with Reversible Pulmonary Arterial Hypertension Secondary to Pulmonary Thromboembolism. - Reversible PAH

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032885
Enrollment
100
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I260- Pulmonary embolism with acute corpulmonale

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed with hemodynamically significant acute PTE and CTEPH during study period will be included after informed written consent.

Exclusion criteria

Exclusion criteria: Patients who did not give consent

Design outcomes

Primary

MeasureTime frame
To study the echocardiographic findings in patients with CTEPH and acute PTE and at follow up of six months after optimal management.Timepoint: To study the echocardiographic findings in patients with CTEPH and acute PTE and at follow up of six months after optimal management.—

Secondary

MeasureTime frame
To study the prevalence of PFO in patients presenting with acute PTE during study period To study the effect of PFO on clinical presentation of patients Timepoint: Six months of follow up—

Countries

India

Contacts

Public ContactRajesh Vijayvergiya

PGIMER

rajeshvijay999@hotmail.com9815221856

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026